Stock Quote
Covidien plc. (COV) (NYSE Arca)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View COV on other exchanges
--
--
--
$45.65
--
--
--
--
$46.75
$27.27
0.58
2,352,465
COV
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Meelia, Richard | Chairman of the Board, President, Chief Executive Officer | 16,969,900 |
| Dockendorff, Charles | Chief Financial Officer, Executive Vice President | 3,372,450 |
| Masterson, John | Senior Vice President, General Counsel | 2,333,770 |
Profile
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company operates its business through four segments: Medical Devices, which includes the development, manufacture and sale of endomechanical... Full Description
Company Address
Covidien plc.
Block G, First Floor
Cherrywood Business Park
Co. Dublin
Block G, First Floor
Cherrywood Business Park
Co. Dublin
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.31 | +0.37 |
| Becton, Dickinson and Co. | $73.70 | +0.24 |
| C.R. Bard, Inc. | $80.72 | -1.17 |
| COV | Industry | |
|---|---|---|
| P/E(TTM) | 25.65 | 3.76 |
| P/S(TTM) | 2.15 | 0.51 |
| ROI(TTM) | -- | 2.54 |
| ROE(TTM) | -- | 4.01 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.81 |
| EPS Est. (Current Year) | 2.86 |
| Total Revenue | $2,697.00M |
| Net Income | $55.00M |
| EPS | $0.11 |
